UK markets closed

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8100+0.0500 (+1.81%)
As of 03:36PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 362.90M
Enterprise value 378.41M
Trailing P/E 68.75
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.84
Price/book (mrq)1.30
Enterprise value/revenue 0.87
Enterprise value/EBITDA 10.50

Trading information

Stock price history

Beta (5Y monthly) 1.58
52-week change 335.29%
S&P500 52-week change 329.57%
52-week high 34.7050
52-week low 31.7950
50-day moving average 33.2816
200-day moving average 33.1639

Share statistics

Avg vol (3-month) 3691.05k
Avg vol (10-day) 3707.24k
Shares outstanding 5131.96M
Implied shares outstanding 6131.96M
Float 862.02M
% held by insiders 133.22%
% held by institutions 144.85%
Shares short (15 Mar 2024) 48.01M
Short ratio (15 Mar 2024) 410.47
Short % of float (15 Mar 2024) 426.30%
Short % of shares outstanding (15 Mar 2024) 46.07%
Shares short (prior month 15 Feb 2024) 47.47M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1.14%
Operating margin (ttm)0.65%

Management effectiveness

Return on assets (ttm)2.24%
Return on equity (ttm)1.82%

Income statement

Revenue (ttm)433.14M
Revenue per share (ttm)3.30
Quarterly revenue growth (yoy)-13.70%
Gross profit (ttm)N/A
EBITDA 31.69M
Net income avi to common (ttm)4.95M
Diluted EPS (ttm)0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)103.84M
Total cash per share (mrq)0.79
Total debt (mrq)121.68M
Total debt/equity (mrq)43.67%
Current ratio (mrq)2.80
Book value per share (mrq)2.12

Cash flow statement

Operating cash flow (ttm)30.92M
Levered free cash flow (ttm)18M